Thrombo Genics Nv

23 email addresses found for thrombogenics.com
{first}.{last}@thrombogenics.com
23 email addresses
http://au.sys-con.com/node/2464765 June 6, 2017
http://au.sys-con.com/node/2500250 August 8, 2015
http://bio-medicine.org/biology-technology-1/thrombogenics-and-bioinvent-receive-approval-to-begin-clinical-trials-of-tb-403-for-the-treatment-of-cancer-2648-4/ August 8, 2015
http://bio-medicine.org/biology-technology-1/thrombogenics-announces-business-update-and-2008-full-year-results-10968-1 March 3, 2016
http://bio-medicine.org/biology-technology-1/thrombogenics-n-v--3a-business-update-8957-1 March 3, 2016
http://bio-medicine.org/biology-technology-1/thrombogenics---positive-microplasmin-phase-ii-data-published-in-ophthalmology-15547-1 May 5, 2017
http://bio-medicine.org/medicine-technology-1/thrombogenics-completes-patient-enrolment-in-us-phase-iii-trial-of-microplasmin-for-the-non-surgical-treatment-of-eye-disease-5051-1 May 5, 2017
http://biospace.com/news/bioinvent-and-thrombogenics-ltd-to-receive-eur-10/180707 July 7, 2017
http://biospace.com/news/fda-advisory-committee-recommends-thrombogenics-nv/268285 May 5, 2017
http://biospace.com/news_print.aspx May 5, 2015
http://biospace.com/news/thrombogenics-nv-completes-private-placement/254729 January 1, 2015
http://biospace.com/News/thrombogenics-nv-novartis-ag-win-eu-ok-for-jetrea/285164 July 7, 2015
http://br.sys-con.com/node/2500250 August 8, 2015
http://drugs.com/clinical_trials/bioinvent-thrombogenics-announce-positive-topline-results-phase-ii-vte-prophylaxis-study-anti-9358.html March 3, 2016
http://drugs.com/clinical_trials/positive-results-phase-ii-vte-prophylaxis-study-tb-402-anti-factor-viii-presented-21st-9790.html March 3, 2016
http://drugs.com/clinical_trials/thrombogenics-presents-new-exciting-microplasmin-phase-iii-data-world-ophthalmology-congress-woc-9542.html March 3, 2016
http://drugs.com/nda/ocriplasmin_120703.html January 1, 2015
http://it.sys-con.com/node/2500250 January 1, 2015
http://news.cision.com/se/bioinvent/r/bioinvent-och-thrombogenics-presenterar-positiva-resultat-fran-fas-ii-studie-av-tromboshammaren-tb-402-vid-internationell-kongress,c503110 March 3, 2018
http://pr.gaeatimes.com/thrombogenics-and-bioinvent-complete-enrollment-of-phase-iib-trial-with-tb-402-ahead-of-schedule-54941 January 1, 2018
http://prnewswire.com/news-releases/new-paper-in-cell-highlights-the-potential-role-of-tb-403-anti-plgf-in-the-treatment-of-medulloblastoma-a-pediatric-brain-tumor-194001881.html January 1, 2015
http://prnewswire.com/news-releases/thrombogenics-and-bioinvent-to-regain-full-rights-to-tb-403-157132965.html May 5, 2015
http://prnewswire.com/news-releases/thrombogenics-founder-prof-desire-collen-receives-scrip-lifetime-achievement-award-233001071.html January 1, 2015
http://prnewswire.com/news-releases/thrombogenics-opens-new-us-headquarters-141445613.html March 3, 2016
http://prnewswire.com/news-releases/us-fda-approves-thrombogenics-jetrea-ocriplasmin-for-the-treatment-of-symptomatic-vitreomacular-adhesion-vma-174705351.html January 1, 2015
http://prnewswire.co.uk/news-releases/thrombogenics-nv---business-update-177907291.html September 9, 2017
http://thestreet.com/story/11776730/3/jetrea-selected-for-single-technology-appraisal-sta-by-the-uks-national-institute-for-health-and-clinical-excellence-nice.html April 4, 2015
http://thestreet.com/story/11871593/1/thrombogenics-starts-trading-as-part-of-the-bel20-index-today.html May 5, 2017
http://thestreet.com/story/11893576/5/thrombogenics-jetrea-the-first-and-only-medicine-for-treating-vitreomacular-traction-now-launched-in-the-uk.html May 5, 2015
http://thestreet.com/story/11997501/4/germanys-iqwig-confirms-that-thrombogenics-jetrea-demonstrates-major-added-value-for-the-treatment-of-vitreomacular-traction-and-macular-hole.html March 3, 2016
http://bio-medicine.org/biology-technology-1/thrombogenics---positive-microplasmin-phase-ii-data-published-in-ophthalmology-15547-1 May 5, 2017
http://bio-medicine.org/medicine-technology-1/thrombogenics-announces-start-of-phase-ii-trial-of-microplasmin-for-the-treatment-of-age-related-macular-degeneration--28amd-29-6919-1 May 5, 2017
http://bio-medicine.org/medicine-technology-1/thrombogenics-begins-phase-iii-program-with-microplasmin-for-the-non-surgical-treatment-of-back-of-the-eye-disease-3676-1 August 8, 2017
http://bio-medicine.org/medicine-technology-1/thrombogenics-completes-patient-enrolment-in-us-phase-iii-trial-of-microplasmin-for-the-non-surgical-treatment-of-eye-disease-5051-1 August 8, 2017
http://bio-medicine.org/medicine-technology-1/thrombogenics-completes-patient-enrolment-of-second-phase-iii-trial-of-microplasmin-for-the-non-surgical-treatment-of-eye-disease-7032-1 August 8, 2017
http://biospace.com/news_print.aspx July 7, 2015
http://biospace.com/news/thrombogenics-ltd-and-bioinvent-complete/244042 February 2, 2015
http://digchip.com/companies_news/2009/2009_10_05_3.php December 12, 2017
http://drugs.com/clinical_trials/microplasmin-meets-primary-endpoint-second-phase-iii-trial-vma-confirms-positive-findings-first-10028.html January 1, 2015
http://drugs.com/clinical_trials/thrombogenics-announces-publication-positive-microplasmin-phase-ii-data-journal-retina-9825.html June 6, 2015
http://drugs.com/clinical_trials/thrombogenics-positive-microplasmin-phase-ii-data-published-ophthalmology-8845.html January 1, 2015
http://drugs.com/clinical_trials/thrombogenics-presents-new-exciting-microplasmin-phase-iii-data-world-ophthalmology-congress-woc-9542.html January 1, 2015
http://drugs.com/clinical_trials/thrombogenics-presents-positive-pooled-results-mivi-trust-phase-iii-program-confirming-microplasmin-10042.html April 4, 2015
http://mynewsdesk.com/se/pressreleases/positiva-resultat-fraan-fas-ii-studie-av-tb-402-publicerade-i-journal-of-thrombosis-and-haemostasis-578962 October 10, 2017
http://news.cision.com/se/bioinvent/r/positiva-resultat-fran-fas-ii-studie-av-tb-402-publicerade-i-journal-of-thrombosis-and-haemostasis,c546424 September 9, 2017
http://pr.gaeatimes.com/thrombogenics-and-bioinvent-complete-enrollment-of-phase-iib-trial-with-tb-402-ahead-of-schedule-54941 July 7, 2016
http://prnewswire.com/news-releases/microplasmin-meets-primary-endpoint-in-second-phase-iii-trial-in-vma-confirms-positive-findings-of-first-trial-101948448.html September 9, 2017
http://prnewswire.com/news-releases/thrombogenics-and-bioinvent-complete-enrollment-of-phase-iib-trial-with-tb-402-ahead-of-schedule-135717238.html May 5, 2015
http://au.sys-con.com/node/2464765 January 1, 2015
http://au.sys-con.com/node/2500248 May 5, 2016
http://au.sys-con.com/node/2500250 March 3, 2016
http://biospace.com/news/fda-thrombogenics-nv-main-drug-cleared-for-u-s/276449 March 3, 2016
http://biospace.com/News/fda-thrombogenics-nv-main-drug-cleared-for-u-s/276449 March 3, 2015
http://biospace.com/news/thrombogenics-nv-novartis-ag-win-eu-ok-for-jetrea/285164 March 3, 2016
http://biospace.com/News/thrombogenics-nv-novartis-ag-win-eu-ok-for-jetrea/285164 July 7, 2015
http://biospace.com/news/thrombogenics-nv-novartis-ag-win-eu-ok-for-jetrea/285164/source=topbreaking January 1, 2015
http://br.sys-con.com/node/2500250 August 8, 2015
http://businesswire.com/news/home/20130228006146/en/bioinvent-paper-cell-highlights-potential-role-tb-403 January 1, 2015
http://businesswire.com/news/home/20170420005248/en/bicycle-therapeutics-announces-candidate-preclinical-milestone-ophthalmology September 9, 2017
http://ca.sys-con.com/node/2500248 April 4, 2015
http://globenewswire.com/news-release/2014/04/14/627031/10076693/en/thrombogenics-nv-market-update.html January 1, 2015
http://in.sys-con.com/node/2464765 May 5, 2016
http://it.sys-con.com/node/2500250 January 1, 2015
http://prnewswire.com/news-releases/j-code-for-thrombogenics-jetrea-to-become-effective-january-1-2014-234181981.html May 5, 2015
http://prnewswire.com/news-releases/new-paper-in-cell-highlights-the-potential-role-of-tb-403-anti-plgf-in-the-treatment-of-medulloblastoma-a-pediatric-brain-tumor-194001881.html January 1, 2015
http://prnewswire.com/news-releases/thrombogenics-founder-prof-desire-collen-receives-scrip-lifetime-achievement-award-233001071.html January 1, 2015
http://prnewswire.com/news-releases/thrombogenics-founder-prof-desire-collen-retiring-as-chairman-234815801.html August 8, 2017
http://prnewswire.com/news-releases/us-fda-approves-thrombogenics-jetrea-ocriplasmin-for-the-treatment-of-symptomatic-vitreomacular-adhesion-vma-174705351.html January 1, 2015
http://prnewswire.co.uk/news-releases/thrombogenics-nv---business-update-177907291.html September 9, 2017
http://quotes.wsj.com/be/thr April 4, 2016
http://thestreet.com/story/11776730/3/jetrea-selected-for-single-technology-appraisal-sta-by-the-uks-national-institute-for-health-and-clinical-excellence-nice.html April 4, 2015
http://thestreet.com/story/11871593/1/thrombogenics-starts-trading-as-part-of-the-bel20-index-today.html May 5, 2017
http://thestreet.com/story/11893576/5/thrombogenics-jetrea-the-first-and-only-medicine-for-treating-vitreomacular-traction-now-launched-in-the-uk.html May 5, 2015
http://thestreet.com/story/11911614/5/thrombogenics-jetrea-available-in-germany-public-and-private-market.html March 3, 2016
http://thestreet.com/story/11997501/4/germanys-iqwig-confirms-that-thrombogenics-jetrea-demonstrates-major-added-value-for-the-treatment-of-vitreomacular-traction-and-macular-hole.html May 5, 2015
http://thrombogenics.com/news-events/press-contact February 2, 2016
http://thrombogenics.com/nl/news-events/press-contact October 10, 2015
http://uk.sys-con.com/node/2500248 January 1, 2015
http://au.sys-con.com/node/2464765 June 6, 2017
http://au.sys-con.com/node/2500248 June 6, 2017
http://au.sys-con.com/node/2500250 August 8, 2015
http://bio-medicine.org/biology-technology-1/thrombogenics-announces-business-update-and-2008-full-year-results-10968-1 March 3, 2016
http://bio-medicine.org/biology-technology-1/thrombogenics-nv-3a-business-update-12110-1 May 5, 2017
http://bio-medicine.org/biology-technology-1/thrombogenics-n-v--3a-business-update-8957-1 March 3, 2016
http://biospace.com/collaborative/news/thromb-x-nv-opens-new-u-s-headquarters/251902 May 5, 2017
http://biospace.com/news_print.aspx May 5, 2015
http://biospace.com/news/thrombogenics-nv-completes-private-placement/254729 January 1, 2015
http://biospace.com/News/thrombogenics-nv-novartis-ag-win-eu-ok-for-jetrea/285164 July 7, 2015
http://biospace.com/news/thrombogenics-nv-novartis-ag-win-eu-ok-for-jetrea/285164/source=topbreaking January 1, 2015
http://br.sys-con.com/node/2500250 August 8, 2015
http://businesswire.com/news/home/20130228006146/en/bioinvent-paper-cell-highlights-potential-role-tb-403 March 3, 2016
http://devicespace.com/news/thrombogenics-ltd-announces-that-the-fda-intends/248212 January 1, 2015
http://drugs.com/nda/ocriplasmin_111227.html March 3, 2016
http://drugs.com/nda/ocriplasmin_120607.html March 3, 2016
http://drugs.com/nda/ocriplasmin_120703.html January 1, 2015
http://in.sys-con.com/node/2464765 May 5, 2017
http://it.sys-con.com/node/2500250 January 1, 2015
http://prnewswire.com/news-releases/new-paper-in-cell-highlights-the-potential-role-of-tb-403-anti-plgf-in-the-treatment-of-medulloblastoma-a-pediatric-brain-tumor-194001881.html January 1, 2015
http://prnewswire.com/news-releases/thrombogenics-and-bioinvent-to-regain-full-rights-to-tb-403-157132965.html May 5, 2015
http://prnewswire.com/news-releases/thrombogenics-founder-prof-desire-collen-receives-scrip-lifetime-achievement-award-233001071.html January 1, 2015
http://prnewswire.com/news-releases/thrombogenics-opens-new-us-headquarters-141445613.html March 3, 2016
http://prnewswire.com/news-releases/us-fda-approves-thrombogenics-jetrea-ocriplasmin-for-the-treatment-of-symptomatic-vitreomacular-adhesion-vma-174705351.html January 1, 2015
http://prnewswire.co.uk/news-releases/thrombogenics-nv---business-update-177907291.html January 1, 2018
http://thestreet.com/story/11530145/3/thrombogenics-nv--business-update.html March 3, 2016
http://thestreet.com/story/11776730/3/jetrea-selected-for-single-technology-appraisal-sta-by-the-uks-national-institute-for-health-and-clinical-excellence-nice.html April 4, 2015
http://thestreet.com/story/11893576/5/thrombogenics-jetrea-the-first-and-only-medicine-for-treating-vitreomacular-traction-now-launched-in-the-uk.html May 5, 2015
http://thestreet.com/story/11997501/4/germanys-iqwig-confirms-that-thrombogenics-jetrea-demonstrates-major-added-value-for-the-treatment-of-vitreomacular-traction-and-macular-hole.html May 5, 2015
http://uk.sys-con.com/node/2500248 March 3, 2016
13 more results for thrombogenics.com. Sign up or log in to access the full results.

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 800,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month..

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about thrombogenics.com

Language of the website: English